Provided By PR Newswire
Last update: Mar 5, 2024
Data to showcase PROphet® platform's machine learning models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy
Read more at prnewswire.com